The objective is to follow participants receiving CAR-T cells from years 2 to 15 post-treatment for persistence of CAR-T cells, development of secondary malignancies, or other medical complications.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All participants who enrolled in a CAR-T study at Froedtert Hospital \& the Medical College of Wisconsin.
Clareo Health | Long-term Follow-up Study of Patients Receiving CAR-T Cells
